Kai Wucherpfennig
InvestorFounderStrategic Advisory Board at Longwood Fund · Board director at Immunitas Therapeutics
FoundedImmunitas Therapeutics
About
Chair of Cancer Immunology and Virology at Dana-Farber, Harvard faculty, and scientific co-founder of Immunitas.
Board director at Immunitas Therapeutics
Intro paths
→
In turn, Kai can intro founders to Immunitas Therapeutics's investors below.
Immunitas Therapeutics's investors · 9
Agent CapitalWaltham · since 2021DC Investment PartnersMcLean · $10M checks · since 2021Leaps by BayerLeverkusen · since 2021Longwood FundBoston · since 2021M VenturesLos Angeles · $10.8M checks · since 2021Medical Excellence CapitalNew York · since 2021Novartis Venture FundBasel · $5M – $25M checks · since 2021Ono Venture Investment, Inc.South San Francisco · since 2021Solasta VenturesBoston · since 2021
Co-founders at Immunitas Therapeutics
AW
Amanda WagnerExecutive Officer
DM
Dan MatloffExecutive Officer
JG
Jiaping GuDirector
JG
Jeffrey GoldbergExecutive Officer, Director
Colleagues at Longwood Fund
Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Frequently asked questions
- Where does Kai Wucherpfennig work?
- Kai Wucherpfennig is Strategic Advisory Board at Longwood Fund and Founder at Immunitas Therapeutics.
- What companies did Kai Wucherpfennig found?
- Kai Wucherpfennig founded Immunitas Therapeutics.